MEF2A expression was concomitant with p38 MAPK and ERK5 activation [126], both of which control a multitude of functions disrupted in preeclampsia, including cell division, differentiation, survival, angiogenesis, and immune responses [127–130]. This evidence concerns the gene MEF2A and preeclampsia.